The recovery of stroke survivors with language difficulties is famously variable. Some stroke survivors recover much more quickly or fully than others. Some respond to treatment much better than others.
Alteplase-Tenecteplase Trial Evaluation for Stroke Thrombolysis (ATTEST 2) - TSA BHF 2015/01
This study will show whether more intensive lowering of blood pressure (BP) in survivors of intracerebral haemorrhage (ICH) is feasible, safe and effective in reducing brain injury. If successful, the study will pave the way for the design a larger definitive trial.
Following a stroke, many treatments are recommended by health professionals, such as medications to prevent another stroke or physiotherapy to help limb weakness. Stroke survivors often have other chronic illnesses and report finding it difficult to follow treatments recommended by their doctors, nurses and therapists.
Cerebral small vessel disease (SVD) is usually associated with high blood pressure, and causes 20% of all strokes. It is the main cause of cognitive changes and dementia associated with stroke. Behavioural symptoms such as apathy are also common in patients with SVD.
TSA LECT 2015/04 Dr Fergus Doubal, University of Edinburgh
The importance of variability in blood pressure after acute stroke
Published in the journal, The Lancet, the findings of the PISCES I study shed more light on the potential use of stem cell treatment for stroke.
Dr Shamim Quadir, Research Communications Manager at the Stroke Association comments.
Presented today at the European Stroke Organisation Conference in Gothenburg, the results of the international WAKE-UP trial suggest that thousands of people who wake up with a stroke each year in the UK could now benefit from life-changing thrombolysis treatment.
PRESS RELEASE - Issued by University of Leicester Press Office on Tuesday 10 May
University of Leicester involved in the international ENCHANTED trial to improve survival rates of stroke victims. Stroke Association funds UK arm of the trial.